Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01026623).
- Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CLANIndependent statistical analysis of Contact Lens Adaptation in Neophytes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02148263).
- Clareon PanOptix Pro vs. Clareon PanOptix – Study A: Complete Statistical AnalysisIndependent statistical analysis of Clareon PanOptix Pro vs. Clareon PanOptix - Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06400745).
- Clareon Toric vs Eyhance Toric: Complete Statistical AnalysisIndependent statistical analysis of Clareon Toric vs Eyhance Toric: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05481125).
- Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00840411).
- CLARITYIndependent statistical analysis of A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant: Complete Statistical AnalysisIndependent statistical analysis of Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03380962).
- CLBP Single-Arm Long-Term Follow-up Study: Complete Statistical AnalysisIndependent statistical analysis of CLBP Single-Arm Long-Term Follow-up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05207813).
- CLEARIndependent statistical analysis of Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CLEAR 2Independent statistical analysis of Combining Lesinurad With Allopurinol in Inadequate Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493531).
- CLEARANCEIndependent statistical analysis of CLinical Evaluation of Aspiration for Removal ANd ClearancE of Stones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06615713).
- CLEOPATRAIndependent statistical analysis of CLEOPATRA, the randomized phase 3 trial of pertuzumab plus trastuzumab and docetaxel versus placebo plus trastuzumab and docetaxel in previously untreated HER2-positive metastatic breast cancer.
- CLEVERIndependent statistical analysis of Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04767373).
- Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage: Complete Statistical AnalysisIndependent statistical analysis of Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals: Complete Statistical AnalysisIndependent statistical analysis of Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Comparison of the Airway Devices: Complete Statistical AnalysisIndependent statistical analysis of Clinical Comparison of the Airway Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00581386).
- Clinical Comparison of Two Silicone-Hydrogel Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Clinical Comparison of Two Silicone-Hydrogel Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00762385).
- Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension: Complete Statistical AnalysisIndependent statistical analysis of Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01515865).
- Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma: Complete Statistical AnalysisIndependent statistical analysis of Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02260492).
- Clinical Evaluation of Effects of an Investigational Tampon on Vaginal Microflora: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of Effects of an Investigational Tampon on Vaginal Microflora: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clinical Evaluation of MDT-2111 in Subjects With Small Aortic Annuli and Symptomatic Severe Aortic Stenosis: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of MDT-2111 in Subjects With Small Aortic Annuli and Symptomatic Severe Aortic Stenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease: primary endpoint results, effect estimate with confidence interval,…
- Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01797562).
- Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL): Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01210807).
- Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00645164).
- Clinical Evaluation of Two Daily Wear Silicon Hydrogel Contact Lens: Complete Statistical AnalysisIndependent statistical analysis of Clinical Evaluation of Two Daily Wear Silicon Hydrogel Contact Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354924).
- Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS): Complete Statistical AnalysisIndependent statistical analysis of Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04115228).
- Clinical Investigation of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL): Complete Statistical AnalysisIndependent statistical analysis of Clinical Investigation of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD): Complete Statistical AnalysisIndependent statistical analysis of Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05575063).
- Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population: Complete Statistical AnalysisIndependent statistical analysis of Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve: Complete Statistical AnalysisIndependent statistical analysis of Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00630916).
- Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays: Complete Statistical AnalysisIndependent statistical analysis of Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System: Complete Statistical AnalysisIndependent statistical analysis of Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II: Complete Statistical AnalysisIndependent statistical analysis of Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Management of Neuropathic Pain With Ramelteon: Complete Statistical AnalysisIndependent statistical analysis of Clinical Management of Neuropathic Pain With Ramelteon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00753623).
- Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine: Complete Statistical AnalysisIndependent statistical analysis of Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03127943).
- Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A: Complete Statistical AnalysisIndependent statistical analysis of Clinical Performance of a Silicone Hydrogel Lens With Use of FID 114675A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System): Complete Statistical AnalysisIndependent statistical analysis of Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Performance of Masimo INVSENSOR00048 (DALI0001): Complete Statistical AnalysisIndependent statistical analysis of Clinical Performance of Masimo INVSENSOR00048 (DALI0001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06922461).
- Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04908488).
- Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study): Complete Statistical AnalysisIndependent statistical analysis of Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs: primary endpoint…
- Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…